Taiwan FDA registration 4bcc809149f53f680fc50772ee877325
VIDAS NT-proBNP2
TW: 威達獅N末端前-B-型利鈉肽第二代試劑組
Taiwan·Risk Class 2·MD·BIOMERIEUX S.A.·Registered Apr 21, 2014 – Apr 21, 2024ExpiredRegistration details
- Analysis ID
- 4bcc809149f53f680fc50772ee877325
- License Form
- Ministry of Health Medical Device Import No. 026064
- Customs Code
- DHA05602606408
Company information
- Manufacturer
- BIOMERIEUX S.A.
- Manufacturer Country
- France
- Authorized Representative
- Hong Kong Commercial Mérieux S.p.A. Taiwan Branch
Product details
- Intended Use
- This product is an automated quantitative test used in the VIDAS series of instruments to detect the N-terminus of B-type natriuretic peptides in human serum or plasma (heparin lithium and heparin sodium) using ELFA technology (enzyme-linked fluorescence analysis).
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1117 Type B sodium urine peptide test system
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Apr 21, 2014
- Expiry Date
- Apr 21, 2024
About this record
Access comprehensive regulatory information for VIDAS NT-proBNP2 in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 4bcc809149f53f680fc50772ee877325 and manufactured by BIOMERIEUX S.A.. The authorized representative in Taiwan is Hong Kong Commercial Mérieux S.p.A. Taiwan Branch.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices